文摘
摘要目的:评估临床实践差距的原因和挑战的卫生保健提供者专门从事女士(HCP-MS),对患者的护理和相关的影响。
背景:HCP-MS面临着发展的治疗和临床环境,患者要求先进的护理管理多方面的条件。因此,差距在知识,技能和信心可能影响HCP-MS做出临床决策的能力和优化病人护理需要评估。
设计/方法:混合方法研究包括333神经学家和135高级执业护士在加拿大、法国、德国、意大利、西班牙、英国和美国,采访或调查。定性数据分析主题。定量数据分析采用方差分析和卡方检验比较的国家的经验,实践设置和认证女士地位。
结果:定性数据显示当前的指导方针被视为管理的复杂需求不足患者认知功能测试女士被视为浪费时间,可能不准确,最好应该由康复专家或精神科医生。调查数据显示,42%的神经学家和61%的护士没有或只有等管理基本技能测试,和分别为44%和67%没有/基本技能解释它们。HCP-MS报道其他因素阻碍临床决策最优个性化护理。加拿大百分之三十九的神经学家(高/意大利/英国,p < . 05)和44%的护士报告没有/基本技能将病人的目标整合到治疗建议。没有/基本技能决定疾病修饰治疗(DMT)测序报告28%的神经学家和62%的护士。一些不良事件被认为具有挑战性:HCP-MS报道no /基本技能鉴定(51%)和管理(61%)感染,和no /基本技能鉴定(47%)和管理(56%)心脏问题。
结论:HCP-MS面临重大挑战提供最佳的护理。本研究确定了需要的专业发展活动,增强技能在认知测试中,DMT决策、治疗监测和病人沟通,同时考虑到女士的演讲的异质性。
披露:博士主要受到个人薪酬在500 - 4999美元的范围为AXDEV担任顾问。博士主要受到个人补偿的范围5000 - 9999美元作为顾问起到了推动作用。博士主要受到个人薪酬在500 - 4999美元的范围为NeuroDiem担任顾问。博士主要受到个人薪酬在500 - 4999美元的范围为神经学学院担任顾问。首页博士主要受到个人薪酬在500 - 4999美元的范围为在科学咨询服务或数据安全监测委员会默克公司。博士主要受到个人薪酬在10000 - 49999美元的范围在默克公司的演讲人。博士主要受到个人薪酬在5000 - 9999美元的范围在f .罗氏公司AG的演讲人。博士主要受到个人薪酬在5000 - 9999美元的范围在诺华的演讲人。博士主要受到个人赔偿范围在5000 - 9999美元的Teva演讲人。博士主要受到个人薪酬在500 - 4999美元的范围在Sanofi-Genzyme演讲人。 Patrice Lazure has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EIT Health. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from EMD-Serono. The institution of Dr. Oh has received research support from Biogen-Idec. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Celgene . Suzanne Murray has nothing to disclose. Sophie Peloquin has received personal compensation in the range of $500-$4,999 for serving as a Expert Evaluator with EIT Health .
